Public Policy Tipoffs Involving Missouri
2024-25 NAIA Women's Wrestling Coaches' Top 20 - No. 6 (February 6)
KANSAS CITY, Missouri, Feb. 6 [Category: Sports] -- The National Association of Intercollegiate Athletics posted the following news release:
* * *
2024-25 NAIA Women's Wrestling Coaches' Top 20 - No. 6 (February 6)
KANSAS CITY, Mo. - The sixth NAIA Women's Wrestling Coaches' Top 20 Rating of the 2024-25 season has Life (Ga.) and Grand View (Iowa) holding strong at first and second, while William Penn (Iowa) jumped three spots to sit in third. Cumberlands (Ky.) and Southern Oregon are knotted
more
COLLEGE OF THE OZARKS LAUNCHES COMMUNITY EDUCATION PROGRAM
POINT LOOKOUT, Missouri, Feb. 7 -- College of the Ozarks issued the following news release:
* * *
COLLEGE OF THE OZARKS LAUNCHES COMMUNITY EDUCATION PROGRAM
College of the Ozarks, affectionately known as "Hard Work U.," is thrilled to announce the launch of its new Community Education Program, beginning in Spring 2025. This exciting initiative invites members of the community to join the College on a journey of learning, exploration, and personal enrichment. From delving into the history of t
more
From Mizzou to Arrowhead: Trevor Lerit, BJ '24, Joins the Chiefs Kingdom Behind the Scenes
COLUMBIA, Missouri, Feb. 7 -- The University of Missouri's School of Journalism issued the following news release:
* * *
From Mizzou to Arrowhead: Trevor Lerit, BJ '24, joins the Chiefs Kingdom behind the scenes
After three years on Team Truman, Trevor Lerit, BJ '24, has started a new chapter as KC Wolf's seasonal assistant, helping the Kansas City Chiefs deliver the iconic experience to fans and businesses alike.
As Truman, Lerit gained valuable experience interacting with fans of all ages
more
Nasal COVID-19 Vaccine Based on WashU Technology to Enter U.S. Clinical Trials
ST. LOUIS, Missouri, Feb. 7 -- The Washington University School of Medicine issued the following news release:
By Tamara Schneider
A nasal vaccine for COVID-19 - based on technology developed at Washington University in St. Louis - is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application from Ocugen, Inc. was approved by the Food and Drug Administration (FDA). Ocugen, a U.S.-based biotechnology company, licensed the innovative technology from WashU
more
